Selecting the Best Heart Valve Replacement Surgeons and Hospitals in India for Canadian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 23-08-2026

In 24 years of guiding international patients into Indian hospitals, this is one of the more rigorously documented findings in this entire series, published directly by the professional body representing Canada's own cardiologists and cardiac surgeons. This isn't speculation or an outside critique; it's the Canadian Cardiovascular Society's own peer-reviewed data, describing the genuine, measurable cost of the wait itself, not just the inconvenience of it. The Society's own language is direct: these event rates are “unacceptably high,” and they rise the longer a patient waits.

Healing Journeys of Canadian Patients

Canadian Patients Share Their Experience

Key Takeaways

• The guide highlights Canadian Cardiovascular Society data showing that waiting for TAVI carries measurable risks. The page 1 chart shows cumulative heart-failure hospitalisation rising to approximately 12% by 80 days, while wait-list mortality reaches approximately 2%. The source describes these event rates as unacceptably high and notes that risk increases with longer waits.
• The page 2 provincial comparison demonstrates substantial variation in Canadian access. Median referral-to-TAVI waits ranged from approximately 71.5 days in Newfoundland to 203 days in Alberta, with the cited research finding that identical patients could face at least 62% longer waits in half of province-to-province comparisons.
• India is presented as a considered alternative because leading cardiac centres perform both TAVI and surgical valve replacement at high volume, allowing the choice of treatment to be based on the patient's anatomy and risk profile rather than which technology is available locally. The guide also highlights English-language care, JCI/NABH accreditation and established structural-heart programmes.
• The selection framework gives 55% weighting to the specialist and 45% to the hospital. Specialist assessment focuses on exact procedural volume, an honest TAVI-versus-surgical discussion, personal involvement in the procedure and complication/mortality data. Hospital assessment includes both treatment pathways, a dedicated catheterisation laboratory, hybrid operating theatre, accreditation and complete procedural records.
• The page 4 qualification table identifies MD Cardiology or MCh Cardiothoracic Surgery as the relevant specialist qualification, followed by 1–2 years of fellowship training in structural heart intervention or valve surgery. Four warning signs are also identified: offering only one treatment approach, quoting a price before reviewing echo/catheter data, vague procedural volume and absence of a dedicated hybrid theatre or cath lab.
• The page 4 cost comparison gives illustrative private costs of approximately C$15,000 in India, C$26,000 in Thailand, C$40,000 in Singapore, C$65,000 in Canada and C$150,000 in the United States for a standard TAVI or surgical valve replacement package. The guide stresses that actual costs vary by valve type and technique and recommends obtaining an itemised quotation.

Quick Facts

Treatment

TAVI & Surgical Heart Valve Replacement

Patients

Canadian Patients

Key Specialists

Interventional Cardiologist / Cardiothoracic Surgeon

Selection Weighting

55% specialist / 45% hospital

Base Qualification

MD Cardiology or MCh Cardiothoracic Surgery

Advanced Training

1–2 year structural heart or valve surgery fellowship

Key Assessment

TAVI versus surgical replacement

Hospital Requirement

Dedicated cath lab & hybrid operating theatre

India Cost

Approximately C$15,000

Canada Cost

Approximately C$65,000

US Cost

Approximately C$150,000

Pre-Travel Records

Echocardiogram & catheterisation data

Treatment Timeline

Typically 2–3 weeks from first consultation

Follow-Up

Canadian cardiologist

Key Warning

Avoid centres offering only one treatment approach

Decision Principle

Prioritise exact procedural volume, appropriate treatment selection and complete cardiac infrastructure.

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

For Canadian patients, the guide recommends comparing centres based on specific procedural expertise rather than price alone. Patients should confirm whether TAVI or surgical replacement is more appropriate, verify the specialist's exact procedure volume and outcomes, ensure the hospital offers both pathways with appropriate infrastructure, and arrange Canadian cardiac follow-up before travelling.

Aortic stenosis is the most common serious valve disease affecting older adults, and Canada's cardiology community has been genuinely proactive in studying exactly what happens to patients while they wait for treatment. This guide exists for patients whose cardiac team has confirmed TAVI or surgical valve replacement is the right path, weighing where and when that treatment should happen.

For patients facing this genuine, well-documented risk, the case for looking seriously at India is a strong one: internationally accredited cardiac centres with genuinely high volume in both TAVI and surgical valve replacement, structural heart teams operating at a scale that reflects the size of the population they serve, and treatment that can typically begin within two to three weeks of your first consultation, all at a fraction of the equivalent Canadian private cost. This isn't a fallback option chosen out of desperation; it's a considered, well-evidenced alternative for patients who understand exactly what the data says about waiting.

A genuine, peer-reviewed postcode lottery for valve replacement

Get your full echocardiogram and catheterisation data together before your first overseas conversation. This inequity finding matters enormously because it removes any illusion that your wait reflects your own clinical urgency alone. Two patients with genuinely identical disease severity, symptoms and risk profile can face a considerably different wait purely because of which province they happen to live in. The researchers behind this study concluded plainly that demand has outpaced the growth in treatment capacity, a structural, system-wide gap rather than anything specific to your own case.

This matters directly for how you should think about your own situation. If you live in a province on the longer end of this range, your genuine wait may already be running considerably longer than what national averages, or even your own cardiologist's general guidance, might suggest. Asking your specific care team for your own province's current median wait, rather than relying on a national figure, is a genuinely useful first step before deciding whether to explore options further afield.

Why India specifically, not just “overseas”

This is worth spelling out plainly, because “medical travel” can sound vague until you see what it actually means in practice. India's leading cardiac centres perform a volume of TAVI and surgical valve replacement procedures, week after week, that reflects the scale of the population they serve, a depth of experience genuinely difficult to match within a Canadian system that its own researchers have confirmed is being outpaced by demand. This is not a compromise reached for cost and speed; for the right case, it is comparable or genuinely greater depth of specific procedural experience, across every level of surgical risk from low to high.

Both transcatheter and surgical valve replacement technique are established, routine daily practice at India's leading structural heart programmes, meaning the choice between approaches can be made on genuine clinical merit for your specific anatomy, not constrained by which technology happens to be available at your local centre. Every consultation, medical record, consent discussion and follow-up letter happens in English, conducted by specialists who trained in programs recognised internationally, many with fellowship experience in Canada, the US or the UK themselves. Leading hospitals hold Joint Commission International accreditation, the same standard used to accredit hospitals across the United States, alongside India's own NABH certification. Put together, this is not a compromise on quality in exchange for speed; for the right case, it is genuinely comparable structural heart care, available in weeks rather than months, at a fraction of the price.

Ten weighted criteria, out of 100

The same weighting that applies across this series applies here: the surgeon or interventional cardiologist carries 55 points, the hospital 45. Part one, judging the specialist: genuine volume in your specific procedure, TAVI or surgical, an honest discussion of which approach suits your risk profile, whether the specialist personally performs the procedure, and candid complication and mortality data specific to valve replacement.

Part two, judging the hospital: a genuine structural heart programme offering both TAVI and surgical options, not one alone, a dedicated cardiac catheterisation lab and hybrid operating theatre, verified international accreditation, and a complete procedural record your Canadian cardiologist can use for ongoing care.

Four Signals That Should Make You Pause

• Only one approach offered, TAVI or surgical, without genuine discussion. A centre offering only one option cannot give you an unbiased recommendation between them.
• A price quoted before your echo and catheter data have been reviewed. Nobody can meaningfully assess your valve, or price the procedure, without seeing your specific results.
• Vagueness about the team's volume in your exact procedure. General reassurance about “extensive cardiac experience” is not an answer.
• No dedicated hybrid theatre or cath lab. Confirm the specific infrastructure exists to support your exact procedure safely.

Canada-specific considerations most patients miss

Ask your cardiologist directly for your specific province's current median wait, not a national figure. Given the documented, substantial variation between provinces, this single question could reveal a considerably different picture than you'd otherwise assume.

Tell your Canadian cardiac team early, not after the fact. Most are more sympathetic to a second opinion than patients expect, particularly given what their own professional society has published about the risk of waiting.

Arrange your ongoing cardiac follow-up before you leave. Confirm your Canadian cardiologist is willing to manage long-term monitoring based on overseas procedural findings.

The Questions, in the Order You Should Ask Them

A closing word

Canada's own cardiovascular society has documented, in its own peer-reviewed data, that the wait for valve replacement carries a genuine, measurable cost in both hospitalisation and mortality, a risk that climbs the longer a patient waits and varies substantially depending purely on which province they call home. For patients facing that documented reality, the case for India is genuinely strong, not a fallback option: internationally accredited structural heart programmes with deep, current volume across both TAVI and surgical technique, and treatment that can typically begin within two to three weeks, at a fraction of the equivalent Canadian private cost.

In 24 years of guiding patients through exactly this decision, the pattern is consistent: those who look closely at what India's leading valve replacement centres actually offer, rather than assuming distance means compromise, generally come away reassured rather than anxious. Weight genuine procedural volume heavily, insist on an honest TAVI-versus-surgical discussion, and travel with a written, itemised quote in hand. For most patients facing a documented, lengthening wait, that combination points clearly toward moving forward.

If you would like a second opinion on your case, send the details and I will look at it properly.

Frequently Asked Questions by Canadians about Heart Valve Replacement Surgeons and Hospitals in India

Why can waiting for valve replacement be a concern?

The guide cites Canadian data showing increasing cumulative rates of heart-failure hospitalisation and wait-list death as time on the TAVI waiting list increases.

How different can TAVI waiting times be across Canada?

The cited provincial comparison shows median waits ranging from 71.5 days in Newfoundland to 203 days in Alberta.

Should I choose TAVI or surgical valve replacement?

The guide recommends an individualised assessment based on anatomy and risk profile, rather than automatically selecting one approach.

Which specialist qualifications should I look for?

The guide highlights MD Cardiology or MCh Cardiothoracic Surgery, followed by dedicated fellowship training in structural heart intervention or valve surgery.

Why is procedural volume important?

Patients are advised to ask specifically about the specialist's volume in their exact procedure, rather than accepting general claims of extensive cardiac experience.

How much can valve replacement cost in India?

The guide gives an illustrative private cost of approximately C$15,000 in India, compared with C$65,000 in Canada and C$150,000 in the US.

What records should I send before travelling?

The guide recommends preparing your echocardiogram and catheterisation data before the first overseas consultation.

What hospital infrastructure should I verify?

A suitable centre should have a dedicated cardiac catheterisation laboratory and hybrid operating theatre, particularly when evaluating TAVI and surgical options.

What should I ask the cardiac specialist?

Ask about their exact procedural volume, why TAVI or surgery is appropriate for your case, whether they will personally perform the procedure, and their complication and mortality data.

What should I arrange before returning to Canada?

Arrange ongoing cardiac follow-up with your Canadian cardiologist and ensure the complete procedural record is available for long-term monitoring.

Sources

• Canadian Cardiovascular Society, Position Statement for Transcatheter Aortic Valve Implantation, Canadian Journal of Cardiology, 2019 — onlinecjc.ca
• Sathananthan & Gin, Inequity in Access to Transcatheter Aortic Valve Replacement: A Pan-Canadian Evaluation of Wait-Times, Canadian Journal of Cardiology, 2020 — pubmed.ncbi.nlm.nih.gov
• National Medical Commission — nmc.org.in
• National Accreditation Board for Hospitals & Healthcare Providers — nabh.co

Page Summary

This guide helps Canadian patients compare heart valve replacement surgeons and hospitals in India, with emphasis on TAVI and surgical expertise, treatment selection, hospital infrastructure, cost and follow-up. Canadian data cited in the guide show substantial variation in access, with median TAVI referral waits ranging from 71.5 to 203 days across the cited provincial comparison. The page 1 chart also shows increasing cumulative risks of heart-failure hospitalisation and wait-list death as TAVI waiting time increases. India is presented as an alternative with structural-heart programmes offering both TAVI and surgical replacement, established procedural experience and internationally accredited hospitals. Illustrative costs are approximately C$15,000 in India, C$65,000 in Canada and C$150,000 in the US.

Citation Block

Field	Information
Topic	Best Heart Valve Replacement Surgeons and Hospitals in India for Canadian Patients
Treatment	TAVI & Surgical Heart Valve Replacement
Patients	Canadian Patients
Specialist	Interventional Cardiologist / Cardiothoracic Surgeon
Selection Weighting	55% specialist / 45% hospital
Key Qualification	MD Cardiology or MCh Cardiothoracic Surgery + relevant fellowship
Treatment Decision	Honest TAVI-versus-surgical assessment
Team Check	Exact procedural volume & complication/mortality data
Infrastructure	Dedicated cath lab & hybrid operating theatre
India Cost	~C$15,000
Canada Cost	~C$65,000
US Cost	~C$150,000
Records Required	Echocardiogram & catheterisation data
Follow-Up	Canadian cardiologist
Warning Signs	Single treatment option, early pricing, vague volume, inadequate infrastructure
Patient Pathway	Echo/catheter data → cardiac consultation → itemised quote → travel/pre-op workup → procedure → team review → Canadian follow-up
Key Decision	Prioritise procedural expertise, unbiased treatment selection and appropriate infrastructure